Delivery Order SPE2DB24D1021-SPE2DB25FEXMN
- Not listed
- The Defense Logistics Agency awarded a $3,565.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in a quantity of 100 units. The delivery order is issued under a firm fixed-price contract with an ultimate completion date of July 21, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award includes no set-aside designation and was awarded...
- The Defense Logistics Agency awarded a delivery order valued at $5,333.24 to AmerisourceBergen Drug Corp for the supply of RYTARY ER (extended-release carbidopa/levodopa) 48.75 mg-195 mg capsules in a quantity of 100 units. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. The pharmaceutical product will be performed and delivered from the vendor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $17,984.04 firm fixed-price delivery order for RYTARY ER (carbidopa-levodopa extended-release) 61.25 mg-245 mg capsules, 100-count bottles, with an ultimate completion date of June 9, 2025. This is a competitively awarded, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,826.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RYTARY ER (extended-release carbidopa/levodopa) 36.25 mg-145 mg capsules, 100-count bottles. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 8, 2025. AmerisourceBergen will fulfill this pharmaceutical supply requirement from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $13,844.36 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Rytary ER (carbidopa-levodopa extended-release) 36.25 mg-145 mg capsules in a quantity of 100 units. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside award. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate...
- This delivery order, awarded August 28, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in quantities of 100 units. The contract carries a ceiling value of $10,351.48 and represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The award was competitively procured without set-aside designation and is being performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Rytary ER (carbidopa/levodopa extended-release) 36.25 mg-145 mg capsules in a quantity of 100 units, valued at $5,499.64. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a $10,368.92 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of RYTARY ER (carbidopa/levodopa extended-release) 23.75 mg-95 mg capsules in a quantity of 100 units. This is a firm fixed-price, non-set-aside contract with a completion date of July 28, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a routine pharmaceutical procurement supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $11,742.38 to AmerisourceBergen Drug Corp for Rytary ER 48.75 mg-195 mg capsules (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. Rytary is a carbidopa-levodopa extended-release medication used to treat Parkinson's disease...
- The Defense Logistics Agency awarded a delivery order valued at $2,102.87 to AmerisourceBergen Drug Corp for RYTARY ER 48.75 mg–195 mg capsules (100 count) on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXMNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $44,283.84 to AmerisourceBergen Drug Corp for the supply of RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in a quantity of 100 units. The contract is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and was awarded on June 6, 2025 without any set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a wide array of pharmaceutical products and medical supplies to support military healthcare systems worldwide. RYTARY ER, a neurological treatment for Parkinson's disease, represents the type of specialized medication the company provides through its federal contract portfolio, which serves critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.3k | 6/6/25 |